The following information is the most accurate and documented data available on psychiatric drug usage in the United States. The information is from IQVia (formerly IMS Health), a company that provides information, services and technology for the healthcare industry. It is the largest vendor of U.S. physician prescribing data. The following data was taken from the IQVia Total Patient Tracker Database for Year 2019, extracted February 2020. To see all drug regulatory agency warnings, studies and documented side effects of the psychiatric drugs prescribed to children, visit our Drug Side Effects Page>>